Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy

CLL Prognostication/Risk Stratification Gene Panel near me in Allahabad

Also referred as
Chronic Lymphocytic Leukaemia Genetic Testing
For men & women
Earliest reports in
19 days
Contains
1 test
Test price:
₹19950
₹21000
5% off
Know when you'll get your report
For sample collection between
6 AM - 11 AM
11 AM - 10 PM
Reporting in
19 days
Know more about this test
<font color='#864291'>Know more about this test</font>
Summary

The CLL Prognostication/Risk Stratification Gene Panel is an advanced genetic test used to assess disease prognosis in Chronic Lymphocytic Leukemia (CLL). It detects specific gene mutations associated with disease progression, treatment response, and overall outcome, helping doctors make informed, personalized treatment decisions. By identifying these genetic changes, the test helps stratify patients into low-, intermediate-, or high-risk categories and guides the selection of the most appropriate management approach, including active surveillance, targeted therapy, or clinical trial options. This test is widely available with Tata 1mg labs at an affordable price in Allahabad. 

Samples required
Blood
Find out
Why is this test booked?
Preparation for this test
Sample Collection
Who will collect your samples?

The CLL Prognostication/Risk Stratification Gene Panel is a Next-Generation Sequencing (NGS)–based molecular test performed on EDTA whole blood samples. It analyzes key genes and mutations linked with the development and behavior of Chronic Lymphocytic Leukemia (CLL), a cancer of the blood and bone marrow that affects white blood cells.

CLL is a heterogeneous disease, meaning it behaves differently in every patient. Some cases progress slowly and require only monitoring, while others are more aggressive and need early intervention. This gene panel helps doctors assess an individual’s risk level and make informed clinical decisions.

The test evaluates mutations in important hotspot, full, and fusion genes associated with CLL and other hematological malignancies:

  • Hotspot genes: ABL1, FLT3, JAK2, MYD88, SF3B1
  • Full genes: SH2B3, TP53
  • Gene fusions: FGFR1, FGFR2, PDGFRA, PDGFRB

By detecting these gene mutations, the test helps doctors stratify patients into risk categories (low, intermediate, or high risk) and decide on the most suitable treatment approach, whether active monitoring, targeted therapy, or clinical trial enrollment.

Doctors may recommend this test for individuals with newly diagnosed CLL, persistent or relapsed disease, or those who show clinical signs of disease progression such as rapid lymphocyte doubling, cytopenias, or organ enlargement.

For this test, it is important to submit the clinical history, previous test results, and a doctor’s prescription at the time of sample collection. The Tata 1mg consolidated Test Requisition Form (TRF) must also be duly filled.

Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for a proper understanding of the test results.

See more

The CLL Prognostication/Risk Stratification Gene Panel analyzes multiple genes in the blood that are linked to the development and progression of Chronic Lymphocytic Leukemia (CLL). It uses advanced PCR-based next-generation sequencing (NGS) to detect genetic mutations and variations that help predict how aggressive the disease might be and how it may respond to treatment.

This panel includes:

Hotspot genes (ABL1, FLT3, JAK2, MYD88, SF3B1): Common regions where mutations often occur in blood cancers.

Full genes (SH2B3, TP53): Entire genes analyzed to identify both common and rare mutations that influence prognosis and therapy response.

Gene fusions (FGFR1, FGFR2, PDGFRA, PDGFRB): Abnormal joining of genes that may drive cancer growth and affect targeted treatment choices.

By studying these genes, the test helps determine disease prognosis, identify high-risk patients, and guide doctors in planning personalized treatment strategies and follow-up care.

See more

The CLL Prognostication/Risk Stratification Gene Panel test is done:

  • To evaluate disease risk and prognosis in newly diagnosed CLL patients
  • To guide treatment decisions and therapy selection
  • To identify high-risk genetic mutations requiring closer monitoring or targeted therapy
  • To assess disease relapse or progression
  • To determine eligibility for clinical trials or new drug therapies
  • Provide your clinical history, previous test reports, and a valid prescription. Tata 1mg consolidated TRF to be filled.
Did you find information useful ?
yesYES
noNO

CLL Prognostication/Risk Stratification Gene Panel test price for other cities

Price inAhmedabadRs. 19950
Price inAsansolRs. 19950
Price inBangaloreRs. 19950
Price inBhopalRs. 19950
Price inBhubaneshwarRs. 19950
Book a CLL Prognostication/Risk Stratification Gene Panel test at home near me
Easy online booking
Easy online booking
Search for tests and packages, book your preferred time slot and enter your address for seamless at-home lab tests.
Live tracking of phlebotomist
Live tracking of phlebotomist
Track our trained phlebotomist's real time location for seamless sample collection.
Safe Sample Collection
Safe Sample Collection
Our phlebotomists follow strict safety protocols to collect samples safely at home and on time.
Sample received at lab
Sample received at lab
Samples are transported securely to our accredited labs with world-class machines for testing by qualified experts.
Quick, Doctor-Verified Reports
Quick, Doctor-Verified Reports
Get doctor-approved reports via email and WhatsApp, with options for doctor follow-ups and AI insights.

Other tests

Contains 1 test
Samples required
Preparations
Why is this test booked?